APA način citiranja

Asselah, J., & Sperlich, C. (2013). Post-docetaxel options for further survival benefit in metastatic castration-resistant prostate cancer: Questions of choice. Canadian Medical Association.

Čikaški stil citiranja

Asselah, Jamil, i Catherine Sperlich. Post-docetaxel Options for Further Survival Benefit in Metastatic Castration-resistant Prostate Cancer: Questions of Choice. Canadian Medical Association, 2013.

MLA način citiranja

Asselah, Jamil, i Catherine Sperlich. Post-docetaxel Options for Further Survival Benefit in Metastatic Castration-resistant Prostate Cancer: Questions of Choice. Canadian Medical Association, 2013.